Christine M. Klaskin
Overview
Christine M. Klaskin received an average of $28K in total compensation at MiNK Therapeutics between 2022 and 2023. Christine Klaskin also received an average of $423K at Agenus from 2006 to 2017.
- 2023
- 2022
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
MiNK TherapeuticsTreasurer
MiNK TherapeuticsTreasurer
AgenusVice President, Finance
AgenusVice President, Finance
AgenusVice President, Finance
AgenusVice President, Finance
AgenusVice President, Finance
AgenusVice President, Finance
AgenusVice President, Finance and Principal Accounting and Financial Officer
AgenusVice President, Finance and Principal Accounting and Financial Officer
Source: SEC filings on April 29, 2024, April 26, 2018, May 8, 2017, April 28, 2016, April 30, 2015, March 10, 2014, April 23, 2013, April 24, 2012, May 3, 2011, March 25, 2010, and April 27, 2009.
Related executives
We found 17 more executives who work or worked at MiNK Therapeutics and Agenus.
Jennifer Buell
MiNK Therapeutics
Chief Executive Officer
Marc van Dijk
MiNK Therapeutics
Chief Scientific Officer
Garo Armen
Agenus
Chief Executive Officer
Jennifer Buell
Agenus
Chief Operating Officer
Evan Kearns
Agenus
General Counsel
Alexander Duncan
Agenus
Chief Technology Officer
Robert Stein
Agenus
Former President, R&D
Jean-Marie Cuillerot
Agenus